Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 10 de 10
Filter
Add more filters










Publication year range
1.
Int Forum Allergy Rhinol ; 3(12): 963-72, 2013 Dec.
Article in English | MEDLINE | ID: mdl-24106202

ABSTRACT

BACKGROUND: We aimed to test the hypothesis that three-dimensional (3D) volume-based scoring of computed tomography (CT) images of the paranasal sinuses was superior to Lund-Mackay CT scoring of disease severity in chronic rhinosinusitis (CRS). We determined correlation between changes in CT scores (using each scoring system) with changes in other measures of disease severity (symptoms, endoscopic scoring, and quality of life) in patients with CRS treated with triamcinolone. METHODS: The study group comprised 48 adult subjects with CRS. Baseline symptoms and quality of life were assessed. Endoscopy and CT scans were performed. Patients received a single systemic dose of intramuscular triamcinolone and were reevaluated 1 month later. Strengths of the correlations between changes in CT scores and changes in CRS signs and symptoms and quality of life were determined. RESULTS: We observed some variability in degree of improvement for the different symptom, endoscopic, and quality-of-life parameters after treatment. Improvement of parameters was significantly correlated with improvement in CT disease score using both CT scoring methods. However, volumetric CT scoring had greater correlation with these parameters than Lund-Mackay scoring. CONCLUSION: Volumetric scoring exhibited higher degree of correlation than Lund-Mackay scoring when comparing improvement in CT score with improvement in score for symptoms, endoscopic exam, and quality of life in this group of patients who received beneficial medical treatment for CRS.


Subject(s)
Cone-Beam Computed Tomography/methods , Imaging, Three-Dimensional , Paranasal Sinuses/diagnostic imaging , Rhinitis/diagnostic imaging , Severity of Illness Index , Sinusitis/diagnostic imaging , Adult , Chronic Disease , Humans , Prospective Studies , Quality of Life , Reproducibility of Results
2.
Int Arch Allergy Immunol ; 158(4): 405-10, 2012.
Article in English | MEDLINE | ID: mdl-22487723

ABSTRACT

BACKGROUND: The risk of cephalosporin administration in patients with a history of penicillin allergy is unclear. Few studies have looked at the risk of cephalosporin administration in children following penicillin skin testing for suspected penicillin allergy. The goal of this study was to determine whether children with penicillin allergy were at increased risk for adverse drug reactions when administered a cephalosporin. METHODS: A retrospective chart review was conducted in pediatric patients (≤18 years) with a history of penicillin allergy and a positive or negative penicillin skin test who were administered a cephalosporin after testing. Charts were reviewed for adverse drug reactions to the cephalosporin. RESULTS: A total of 173 patients (91 males) were included in this study. The mean age of the patients was 4.1 ± 3.1 years. Twenty-one patients (12%) tested positive in a penicillin skin test and 152 patients (88%) tested negative. One patient with a negative penicillin skin test (0.7%) had an adverse drug reaction (eye swelling) to cephalexin. None of the patients with a positive penicillin skin test who received a course of cephalosporin had an adverse drug reaction. CONCLUSION: Among all patients with a history of penicillin allergy (penicillin skin test positive and negative), only 1 person had an adverse drug reaction. Further large prospective studies examining the safety of administering cephalosporins in pediatric patients with confirmed penicillin allergy are needed.


Subject(s)
Anti-Bacterial Agents/adverse effects , Cephalosporins/adverse effects , Drug Hypersensitivity/epidemiology , Drug Hypersensitivity/etiology , Penicillins/adverse effects , Anti-Bacterial Agents/therapeutic use , Cephalosporins/therapeutic use , Child , Child, Preschool , Female , Humans , Infant , Male , Retrospective Studies , Skin Tests , Treatment Outcome
3.
Am J Clin Dermatol ; 10(4): 239-50, 2009.
Article in English | MEDLINE | ID: mdl-19489657

ABSTRACT

Urticaria is defined as wheals consisting of three features: (i) central swelling of various sizes, with or without surrounding erythema; (ii) pruritus or occasional burning sensations; and (iii) the skin returning to normal appearance, usually within 1-24 hours. Angioedema is defined as: (i) abrupt swelling of the lower dermis and subcutis; (ii) occasional pain instead of pruritus; (iii) commonly involving the mucous membranes; and (iv) skin returning to normal appearance, usually within 72 hours. Acute urticaria and angioedema is defined by its duration (<6 weeks) compared with chronic urticaria and angioedema. The most common causes are infections, medications, and foods. The best tools in the evaluation of these patients are a comprehensive history and physical examination. There are a variety of skin conditions that may mimic acute urticaria and angioedema and the various reaction patterns associated with different drugs. Oral antihistamines are first-line treatment. In the event of a life-threatening reaction involving urticaria with angioedema, epinephrine may be needed to stabilize the patient. This review focuses on the value of a comprehensive clinical evaluation at the onset of symptoms. It underscores the importance of coordination of care among physicians, and the development of an action plan for evidence-based investigations, diagnosis, and therapy.


Subject(s)
Urticaria/diagnosis , Urticaria/drug therapy , Acute Disease , Adrenergic Agents/administration & dosage , Angioedema/diagnosis , Angioedema/drug therapy , Angioedema/epidemiology , Angioedema/genetics , Causality , Complement C1 Inhibitor Protein/metabolism , Complement C1 Inhibitor Protein/therapeutic use , Drug Therapy, Combination , Emergency Medical Services/methods , Epinephrine/administration & dosage , Genetic Predisposition to Disease , Glucocorticoids/administration & dosage , Histamine Antagonists/administration & dosage , Humans , Leukotriene Antagonists/administration & dosage , Prognosis , Urticaria/epidemiology , Urticaria/physiopathology
4.
Mayo Clin Proc ; 83(6): 651-62, 2008 Jun.
Article in English | MEDLINE | ID: mdl-18533082

ABSTRACT

OBJECTIVE: To study whether allergy consultation and penicillin allergy skin testing affects the selection of antibacterial prophylaxis perioperatively in surgical patients with history of allergy to penicillin (HOAP). PATIENTS AND METHODS: From January 1 through June 30, 2004, we compared 2 different models of practice at our institution. At the Preoperative Evaluation Clinic (POEC), all patients with HOAP are evaluated by an allergist and undergo skin testing for allergy to penicillin. At other (non-POEC) preoperative evaluation settings (OPES), patients with HOAP do not undergo allergy consultation and penicillin skin testing before surgery. Of the 4889 patients screened at the POEC during the study period, 412 consecutive patients with HOAP were included in the study. Of the 416 patients screened at OPES, 69 consecutive patients with HOAP were studied. Logistic regression was used to assess whether allergy consultation was associated with the choice of antibiotic for antibacterial prophylaxis perioperatively, after adjusting for age, sex, and type of surgery. RESULTS: Perioperative cephalosporin use was greater among patients screened at POEC vs those screened at OPES (70% vs 39%, P<.001 unadjusted; P=.04 adjusted for age, sex, and type of surgery). Vancomycin use was lower for patients screened at POEC vs those screened at OPES (10% vs 28%, P<.001 unadjusted; P=.03 adjusted). CONCLUSION: For patients with HOAP, evaluation at the POEC was associated with increased use of cephalosporin and decreased use of vancomycin.


Subject(s)
Anti-Bacterial Agents/adverse effects , Antibiotic Prophylaxis , Drug Hypersensitivity/diagnosis , Penicillin G/adverse effects , Preoperative Care , Skin Tests/methods , Aged , Anti-Bacterial Agents/therapeutic use , Cephalosporins/therapeutic use , Female , Humans , Male , Middle Aged , Perioperative Care , Vancomycin/therapeutic use
5.
Immunol Allergy Clin North Am ; 26(4): 739-51, 2006 Nov.
Article in English | MEDLINE | ID: mdl-17085288

ABSTRACT

The treatment of idiopathic, chronic, recurrent angioedema with or without urticaria is difficult, both for patients and their physicians, because treatment often is only partially effective and is labor-intensive, expensive, and lengthy. New medications for urticaria and angioedema that currently are being tested clinically may prove effective.


Subject(s)
Angioedema , Angioedema/diagnosis , Angioedema/etiology , Angioedema/therapy , Diagnosis, Differential , Humans , Recurrence
6.
Can J Anaesth ; 53(10): 989-93, 2006 Oct.
Article in English | MEDLINE | ID: mdl-16987853

ABSTRACT

PURPOSE: To report a first case of probable anaphylactoid reaction to 6% hydroxyethyl starch reconstituted in balanced electrolyte and glucose solution (Hextend). CLINICAL FEATURES: A 22-yr-old man was admitted for a partial nephrectomy. Near the end of the four-hour operation, an infusion of Hextend was initiated. Shortly thereafter, mechanical ventilation became difficult, peak inspiratory pressure increased to 55 cm H2O with audible wheezing over the patient's lungs. Blood pressure suddenly decreased to 68/46 mmHg. Multiple doses of phenylephrine, ephedrine and epinephrine were required to restore the patient's blood pressure. Postoperatively, a diffuse urticarial rash was apparent on his upper torso. The patient recovered uneventfully. His postoperative serum tryptase was 26.3 ng x mL(-1) (reference range, < 11.5 ng x mL(-1)) and the urine N-methyl-histamine was 2448 microg x g(-1) creatinine (reference range, 30-200 microg x g(-1) creatinine). Two months after the event, skin testing was conducted to test for possible allergy to latex, lidocaine, propofol, cisatracurium, succinylcholine, vecuronium, midazolam, fentanyl, ondansetron, neostigmine, and cephazolin, and all were negative. Hextend was also tested, starting with a 1:100,000 dilution and the results were negative. CONCLUSIONS: The temporal relationship of severe hypotension, bronchospasm and skin rash within ten minutes from administration of Hextend in this patient suggests an immediate hypersensitivity reaction to hetastarch. The elevated levels of serum tryptase and urinary N-methyl-histamine suggest that this hypersensitivity was mediated from mast cell degranulation. Negative skin testing suggests that the reaction was anaphylactoid.


Subject(s)
Anaphylaxis/chemically induced , Hydroxyethyl Starch Derivatives/adverse effects , Plasma Substitutes/adverse effects , Adult , Anaphylaxis/blood , Humans , Intraoperative Period , Male , Tryptases/blood
7.
J Allergy Clin Immunol ; 114(6): 1369-75, 2004 Dec.
Article in English | MEDLINE | ID: mdl-15577837

ABSTRACT

BACKGROUND: Chronic rhinosinusitis (CRS) is one of the most common long-term illnesses in the United States. The etiology of CRS is unknown, and no effective treatment has been established. OBJECTIVE: We investigated the hypothesis that abnormal immunologic responses to ubiquitous airborne fungi contribute to the pathogenesis of this disease. METHODS: The proliferative and cytokine responses of PBMCs to extracts from 4 common airborne fungi-including Alternaria , Aspergillus , Cladosporium , and Penicillium -were examined by in vitro culture. Serum specimens were tested for specific IgE and IgG to these fungi. RESULTS: PBMCs from approximately 90% of the patients with CRS, but not those from normal individuals, produced both IL-5 and IL-13 when exposed to Alternaria. Furthermore, PBMCs from patients with CRS produced significantly more IFN-gamma than PBMCs from normal individuals in response to Alternaria (median, 553 pg/mL vs 98 pg/mL; P < .01). Levels of serum IgG antibodies to Alternaria and Cladosporium were clearly increased in patients with CRS compared with normal individuals ( P < .01). Less than 30% of the patients with CRS had specific IgE antibodies to Alternaria or Cladosporium. The increased humoral (serum IgG) response strongly correlated with the increased cellular (IL-5 production) response to Alternaria ( r = 0.619; P < .01). CONCLUSION: Patients with CRS show exaggerated humoral and cellular responses, both T(H)1 and T(H)2 types, to common airborne fungi, particularly Alternaria. The anomalous immune and inflammatory responses to ubiquitous fungi may explain the chronicity of airway inflammation in CRS.


Subject(s)
Air Microbiology , Fungi/immunology , Rhinitis/etiology , Sinusitis/etiology , Adult , Aged , Alternaria/chemistry , Chronic Disease , Cytokines/biosynthesis , Eosinophil Major Basic Protein/analysis , Female , Fungal Proteins/analysis , Humans , Interleukin-5/analysis , Male , Middle Aged
8.
J Allergy Clin Immunol ; 113(5): 853-9, 2004 May.
Article in English | MEDLINE | ID: mdl-15131566

ABSTRACT

BACKGROUND: In 2 prior uncontrolled studies, nebulized lidocaine reduced oral glucocorticoid use in patients with severe glucocorticoid-dependent asthma. OBJECTIVE: We tested the safety and efficacy of nebulized lidocaine in a randomized, placebo-controlled study in patients with mild-to-moderate asthma. METHODS: We recruited 50 subjects (25 receiving lidocaine and 25 receiving placebo); all had a prebronchodilator FEV(1) of 64% to 125% of predicted normal value and were treated with daily inhaled glucocorticoids (but not systemic glucocorticoids) and bronchodilators for at least 2 months. Before treatment, subjects monitored their symptoms and peak flow values and maintained their medications for 2 weeks. At initiation, subjects inhaled either nebulized placebo (saline) or lidocaine (4%, 100 mg) 4 times daily. All subjects were instructed to reduce their inhaled glucocorticoid dosage by one half each week for 3 weeks and to discontinue glucocorticoid treatment at week 4. The subjects continued the nebulized lidocaine or placebo for a total of 8 weeks, monitored their symptoms, and used bronchodilators to control symptoms. RESULTS: Indicators of asthma severity showed benefit for the lidocaine-treated group: changes in FEV(1) (P < or =.001), nighttime awakenings (P < or =.02), symptoms (P < or =.010), bronchodilator use (P < or =.010), and blood eosinophil counts (P < or =.020). Subjects in both groups reduced use of inhaled glucocorticoids comparably. Subjects receiving nebulized placebo showed increases in their symptom scores, bronchodilator use (P < or =.05 for both), and blood eosinophil counts (P < or =.01) and decreases in FEV(1) (P < or =.001). CONCLUSION: Nebulized lidocaine provided effective and safe therapy in subjects with mild-to-moderate asthma.


Subject(s)
Anti-Asthmatic Agents/administration & dosage , Asthma/drug therapy , Lidocaine/administration & dosage , Administration, Inhalation , Adolescent , Adult , Anti-Asthmatic Agents/adverse effects , Asthma/blood , Asthma/physiopathology , Eosinophils , Female , Forced Expiratory Volume , Glucocorticoids/administration & dosage , Humans , Leukocyte Count , Lidocaine/adverse effects , Male , Middle Aged , Nebulizers and Vaporizers , Safety
9.
Clin Rev Allergy Immunol ; 23(2): 217-31, 2002 Oct.
Article in English | MEDLINE | ID: mdl-12221866

ABSTRACT

Angioedema is a constellation of syndromes that present a great challenge to the clinician. The term "angioedema" describes the localized, transient, episodic edema of the deeper layers of the skin or of the mucosa of the gastrointestinal tract. Although angioedema may affect any part of the body, the skin and gastrointestinal tract are involved most commonly by far. Episodic abdominal pain arising from angioedema affecting any intra-abdominal organ may occur without skin angioedema; therefore, angioedema must be included in the differential diagnosis of intermittent, unexplained abdominal pain. Angioedema is caused by extravasation of plasma in the affected areas, which at times is accompanied by nonspecific, minimal cellular infiltrate. The most commonly identified causes of angioedema are medications, allergens, and physical agents, but most angioedema is idiopathic. Rare forms of angioedema associated with either hereditary or acquired faulty activation of the complement and kallikrein-kinin systems have been extensively described. Taking a comprehensive personal and family history, performing a physical examination, and compulsively monitoring the response to therapy are the most rewarding and cost-effective diagnostic and treatment tools. Diligent and knowledgeable follow-up by the attending physician spares patients costly and unnecessary tests as well as harmful treatment. The most effective treatment depends on the identification of the causative mechanism and--especially when the mechanism is not identified--on the clinician's knowledge and experience with innovative therapeutic regimens.


Subject(s)
Angioedema , Angioedema/diagnosis , Angioedema/diagnostic imaging , Angioedema/immunology , Angioedema/therapy , Diagnosis, Differential , Humans , Radiography
10.
J Clin Gastroenterol ; 34(1): 57-61, 2002 Jan.
Article in English | MEDLINE | ID: mdl-11743247

ABSTRACT

Isolated angioedema, without urticaria or itching, occurs as a result of an inherited or acquired defect in C1 esterase inhibitor activity. Most cases of isolated angioedema are caused by one of two types of hereditary angioedema (HAE). We present a case of the much rarer type II HAE with abdominal pain as the sole presenting symptom. Hereditary angioedema should be suspected in young adults with episodic abdominal pain for which common causes have been excluded. A history of HAE or episodic abdominal pain in family members is not necessary for diagnosis.


Subject(s)
Abdominal Pain/etiology , Angioedema/complications , Abdominal Pain/diagnosis , Abdominal Pain/genetics , Adult , Angioedema/diagnosis , Angioedema/genetics , Diagnosis, Differential , Humans , Male , Recurrence
SELECTION OF CITATIONS
SEARCH DETAIL
...